Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients
暂无分享,去创建一个
Paola Giunti | Bart P C van de Warrenburg | Sylvia Boesch | Bela Melegh | Thomas Klockgether | Tanja Schmitz-Hübsch | Maryla Rakowicz | Caterina Mariotti | Christoph Globas | S. Tezenas du Montcel | T. Schmitz-Hübsch | T. Klockgether | A. Dürr | B. Kremer | P. Giunti | S. Boesch | B. Melegh | C. Mariotti | Jun-Suk Kang | C. Globas | Jun-Suk Kang | Alexandra Dürr | Sophie Tezenas du Montcel | Laszlo Baliko | Sara Bonato | Roberto Fancellu | Berry Kremer | Rafal Rola | Sylvie Romano | Lodger Schöls | Sandra Szymanski | Elzbieta Zdzienicka | R. Rola | R. Fancellu | M. Rakowicz | S. Szymanski | S. Bonato | L. Balikó | E. Zdzienicka | L. Schöls | B. V. D. van de Warrenburg | Sylvie Romano
[1] A. Durr,et al. Clinical and genetic aspects of spinocerebellar degeneration , 2000, Current opinion in neurology.
[2] J. Wuu,et al. Tremor and ataxia in fragile X premutation carriers: Blinded videotape study , 2003, Annals of neurology.
[3] Elsdon Storey,et al. Inter‐rater reliability of the International Cooperative Ataxia Rating Scale (ICARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.
[4] H. Diener,et al. Chapter 17 – Coordination and Ataxia , 2007 .
[5] L. Provinciali,et al. Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[6] K. Nakashima,et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration , 2002, Journal of the Neurological Sciences.
[7] Jan B. M. Kuks,et al. Textbook of Clinical Neurology , 2003 .
[8] M. Hallett,et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.
[9] K. Jellinger,et al. A Textbook of Clinical Neurology , 1928, The Indian Medical Gazette.
[10] Thorsten Schmidt,et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.
[11] W. Poewe,et al. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy , 2002, Movement disorders : official journal of the Movement Disorder Society.
[12] E. Monrós,et al. Friedreich's ataxia: idebenone treatment in early stage patients. , 2002, Neuropediatrics.
[13] F. Mahoney,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.
[14] T Klockgether,et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.
[15] M. Maschke,et al. Eyeblink conditioning in patients with hereditary ataxia: a one-year follow-up study , 2005, Experimental Brain Research.
[16] M. Manto,et al. Effects of the oral form of ondansetron on cerebellar dysfunction , 2003, Journal of Neurology.